IP Verse

Gillard, Richard Edward opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Gillard, Richard Edward

Patent Number:
EP3395339
Title:
Rapid Dissolution Formulation Of A Cinacalcet Hcl
Applicant:
AMGEN INC.
Opposition Date:
Jan 16, 2020
Patent Number:
EP3395340
Title:
Rapid Dissolution Formulation Of Cinacalcet Hcl
Applicant:
AMGEN INC.
Opposition Date:
Jan 16, 2020
Patent Number:
EP1633766
Title:
Modified Fluorinated Nucleoside Analogues
Applicant:
GILEAD PHARMASSET LLC
Opposition Date:
Dec 5, 2019
Patent Number:
EP2981271
Title:
Therapeutic Uses Of Empagliflozin
Applicant:
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Opposition Date:
Aug 14, 2019
Patent Number:
EP3004388
Title:
Detection And Quantification Of Donor Cell-Free Dna In The Circulation Of Organ Transplant Recipients
Applicant:
CHRONIX BIOMEDICAL
Opposition Date:
Jul 31, 2019
Patent Number:
EP2709613
Title:
Methods For Treating Hcv
Applicant:
GILEAD PHARMASSET LLC
Opposition Date:
Aug 22, 2018
Patent Number:
EP2822777
Title:
Multi-Layer Printing Process
Applicant:
AMCOR GROUP GMBH
Opposition Date:
Jul 11, 2018

Competitors of Gillard, Richard Edward

AMGEN INC.

AMGEN, INC

GILEAD PHARMASSET LLC

Want to track Gillard, Richard Edward?

Feel free to send us a message here and we will get back to you